- An autologous dendritic cell vaccine promotes anticancer immunity in patients with ovarian cancer with low mutational burden and cold tumors2022 | Second Faculty of Medicine, Central Library of Charles University, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin2002 | Second Faculty of Medicine
- Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial2021 | Central Library of Charles University, Faculty of Medicine in Pilsen, First Faculty of Medicine
- Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer The VIABLE Phase 3 Randomized Clinical Trial2022 | Faculty of Medicine in Hradec Králové
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. AGS-003-007Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: AGS-003-007Publication without faculty affiliation
- Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial2022 | Second Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine
- Generation of T cell effectors using tumor cell-loaded dendritic cells for adoptive T cell therapy2016 | Second Faculty of Medicine
- Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria2012 | Second Faculty of Medicine